Safety and efficacy of Intralipid emulsions of amphotericin B.
Herbrecht
R
R
Letscher
V
V
D000666:Amphotericin B / Q000009:adverse effects* / Q000627:therapeutic use*; D000935:Antifungal Agents / Q000009:adverse effects / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004334:Drug Administration Schedule; D005217:Fat Emulsions, Intravenous / Q000008:administration & dosage* / Q000627:therapeutic use; D006801:Humans; D007898:Leishmaniasis, Visceral / Q000188:drug therapy
D000935:Antifungal Agents; D005217:Fat Emulsions, Intravenous; D000666:Amphotericin B